Parameters to Consider during preparation of Master Protocols for Oncology Drugs and Biologics
PPosted in -
Oncology Clinical Trials in India Archives
February 23, 2021
INTRODUCTION In our last blog on Master protocols, we discussed the definition of master protocol, the types and advantages of using Master Protocol in clinical trials. In today’s article, we will like to present before you the parameters that are kept in consideration while designing a master protocol for oncology drugs and biologics. During the […]
Current advances in LC-MSMS methods to determine large molecules of drugs in biological samples
Posted in -
Bioanalytical Method Development
February 23, 2021
With many new therapeutics approved annually, the demand for biologics has seen exponential growth in the pharmaceutical market. In the bioanalytical community, the study of large molecules is now a hot topic of discussion. The snowballing importance of peptides and proteins as therapeutic agents, combined with the colossal opportunities offered by new MS-based technology, has […]
MASTER PROTOCOLS IN CLINICAL TRIALS: Basket Trials, Umbrella Trials, Platform Trials
Posted in -
Clinical Research
February 23, 2021
Introduction The aim of drug research and development is to create new drugs that extends longevity and increases the quality of patient life from a disease while being utmost safe. Drug development involves stringent regulatory guidelines that look into the safety and efficacy of the investigational product right from its identification to its post marketing […]